For decades, diabetes has largely been understood through two dominant lenses: type 1, an autoimmune condition, and type 2, commonly linked to obesity and lifestyle. But a newly recognized condition, type 5 diabetes, is challenging those assumptions and forcing the global medical community to rethink what diabetes really looks like.
After nearly 70 years of being overlooked, type 5 diabetes has now been officially recognized by the International Diabetes Federation (IDF), bringing long-overdue attention to a form of the disease that primarily affects young, slim, and often undernourished people, particularly in low- and middle-income countries.
Type 5 diabetes was first identified in 1955 in Jamaica by Dr. Philip Hugh-Jones, who observed patients with diabetes symptoms that did not fit type 1 or type 2. Initially termed “Type J”, the condition later appeared in global health literature as malnutrition-related diabetes mellitus and was briefly classified by the World Health Organization in the 1980s.
However, due to limited evidence and research, the classification was dropped in 1999, leaving millions of patients misdiagnosed—or not diagnosed at all.
Diabetes develops when the body cannot produce enough insulin or cannot use it effectively. What makes type 5 diabetes distinct is how insulin deficiency occurs.
Experts now believe people with type 5 diabetes:
As a result, insulin production is insufficient, but not absent—placing type 5 diabetes somewhere between type 1 and type 2, yet clearly separate from both.
According to current estimates, up to 25 million people worldwide may be living with type 5 diabetes, most of them undiagnosed.
Type 5 diabetes is most commonly seen in:
Experts also warn that refugees, migrants, and people with eating disorders may be at higher risk—even in high-income countries.
The symptoms of type 5 diabetes closely resemble those of Type 1 diabetes, including:
These symptoms also overlap with signs of malnutrition, such as weight loss and persistent hunger, making diagnosis even more challenging.
Because patients are young and thin, many are incorrectly diagnosed with type 1 diabetes and placed on full-dose insulin therapy—which can be ineffective or even dangerous.
Unlike type 1 diabetes, where insulin is essential for survival, patients with type 5 diabetes often respond poorly to insulin therapy. In some cases, insulin can cause dangerously low blood sugar levels.
Instead, emerging evidence suggests treatment should focus on:
This nutritional-first approach reflects the root cause of the disease: impaired pancreatic development due to malnutrition, not autoimmune destruction.
Interest in type 5 diabetes surged after the Young-Onset Diabetes in Sub-Saharan Africa (YODA) study, published in The Lancet Diabetes & Endocrinology.
Researchers studied nearly 900 young adults previously diagnosed with type 1 diabetes and found that:
A follow-up call to action in The Lancet Global Health urged international health bodies to formally recognize this distinct diabetes phenotype, warning that misdiagnosis has harmed millions of lives worldwide.
Diabetes already affects hundreds of millions of people worldwide. Misclassifying type 5 diabetes:
According to experts, some patients with untreated or mismanaged type 5 diabetes do not survive beyond a year after diagnosis—a stark reminder of the consequences of delayed recognition.
If a young, underweight patient presents with diabetes symptoms, especially with a history of food insecurity, type 5 diabetes should be considered. Proper diagnosis requires:
As research continues, global recognition of type 5 diabetes marks a crucial shift toward more equitable, accurate, and life-saving diabetes care.
CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for expert tips, health updates, and the latest medical research straight to your phone.